First Tracks Biotherapeutics Statistics
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
41.64-2.82 (-6.34%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
First Tracks Biotherapeutics by the numbers
First Tracks Biotherapeutics has a market capitalization of $1.75 billion based on 42.02M shares outstanding. With trailing EPS of $-4.71, First Tracks Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.1% above its 50-day average and 30.0% above its 200-day average.
Average daily trading volume is 826.70K shares, or about $34.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRAX valuation vs. peer median
| Metric | TRAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.75B | $1.74B | +1% |
| Avg. volume | 826.70K | 1.05M | -22% |
Peer median across 8 companies: STOK, ETON, SDGR, KRSA, ZYME, MRVI, RARE, BRVE.
Valuation
- Market cap
- $1.75B
- EPS (TTM)
- $-4.71
- Shares outstanding
- 42.02M
Price and trading
- Previous close
- 44.46
- Open
- 43.99
- Day range
- 41.51 – 44.51
- 52-week range
- 14.72 – 54.78
- Beta
- —
- Volume
- 504.36K
- Average volume
- 826.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 1.75B
- Forward Pe
- -12.03
- Eps
- -4.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 54.78
- Week52 Low
- 14.72
- Avg Volume
- 826.70K
- Shares Outstanding
- 42.02M
- Ma50
- 40.39
- Ma200
- 32.04
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -23.99%
- Pct From52w Low
- 182.88%